Literature DB >> 2010770

Fatigue and melatonin in Parkinson's disease.

P H Critchley, G P Malcolm, P N Malcolm, W R Gibb, J Arendt, J D Parkes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2010770      PMCID： PMC1014313          DOI： 10.1136/jnnp.54.1.91

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  3 in total

1.  Direct radioimmunoassay for melatonin in plasma.

Authors:  S Fraser; P Cowen; M Franklin; C Franey; J Arendt
Journal:  Clin Chem       Date:  1983-02       Impact factor: 8.327

2.  Some effects of melatonin and the control of its secretion in humans.

Authors:  J Arendt; C Bojkowski; S Folkard; C Franey; V Marks; D Minors; J Waterhouse; R A Wever; C Wildgruber; J Wright
Journal:  Ciba Found Symp       Date:  1985

3.  Immunoassay of 6-hydroxymelatonin sulfate in human plasma and urine: abolition of the urinary 24-hour rhythm with atenolol.

Authors:  J Arendt; C Bojkowski; C Franey; J Wright; V Marks
Journal:  J Clin Endocrinol Metab       Date:  1985-06       Impact factor: 5.958
  3 in total
  3 in total

Review 1.  Circadian rhythms in neurodegenerative disorders.

Authors:  Malik Nassan; Aleksandar Videnovic
Journal:  Nat Rev Neurol       Date:  2021-11-10       Impact factor: 42.937

2.  A Histologic Study of the Circadian System in Parkinson Disease, Multiple System Atrophy, and Progressive Supranuclear Palsy.

Authors:  Eduardo De Pablo-Fernández; Robert Courtney; Thomas T Warner; Janice L Holton
Journal:  JAMA Neurol       Date:  2018-08-01       Impact factor: 18.302

Review 3.  The Pathophysiology of Fatigue in Parkinson's Disease and its Pragmatic Management.

Authors:  Vladimir S Kostić; Aleksandra Tomić; Milica Ječmenica-Lukić
Journal:  Mov Disord Clin Pract       Date:  2016-03-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.